Relatlimab [CAS 1673516-98-7]
Partner: MedChemexpress LLC
| CAS No: | 1673516-98-7 |
| Applications: | Cancer-programmed cell death |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Relatlimab] |
| Purity: | 97.78 |
| Description: | Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
